We are live on
!
Find out more
SCM
Sterling Capital Management Portfolio holdings
AUM
$5.9B
1-Year Est. Return
29.63%
This Fund
S&P 500
This Quarter
Est. Return
+17.46%
1 Year Est. Return
+29.63%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$5.9B
AUM Growth
+$620M
(+12%)
Cap. Flow
-$8.35M
Cap. Flow
% of AUM
-0.14%
Top 10 Holdings %
Top 10 Hldgs %
23.55%
Holding
3,465
New
250
Increased
687
Reduced
2,249
Closed
176
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Philip Morris
PM
|
+$43.1M |
| 2 |
Devon Energy
DVN
|
+$24.8M |
| 3 |
Coca-Cola Europacific Partners
CCEP
|
+$20.7M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$19.6M |
| 5 |
Micron Technology
MU
|
+$17.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Marvell Technology
MRVL
|
+$47.2M |
| 2 |
Microsoft
MSFT
|
+$38.2M |
| 3 |
Apple
AAPL
|
+$37M |
| 4 |
Amazon
AMZN
|
+$35.5M |
| 5 |
CTRA
Coterra Energy
CTRA
|
+$34.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 21.44% |
| 2 | Technology | 20.51% |
| 3 | Financials | 13.46% |
| 4 | Industrials | 10.73% |
| 5 | Healthcare | 7.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2426
iShares MSCI South Korea ETF
EWY
$29B
| $6.06K | ﹤0.01% |
+30
| New | +$5.29K |
|
|
TECX
2427
Tectonic Therapeutic
TECX
$594M
| $6.05K | ﹤0.01% |
176
-137
| -44% | -$4.03K |
|
2428
Johnson Outdoors
JOUT
$473M
| $6.03K | ﹤0.01% |
131
-67
| -34% | -$3.18K |
|
|
RJET
2429
Republic Airways Holdings
RJET
$828M
| $6.03K | ﹤0.01% |
+287
| New | +$5.6K |
|
2430
Matrix Service
MTRX
$306M
| $6.03K | ﹤0.01% |
440
-291
| -40% | -$3.75K |
|
2431
Rocky Brands
RCKY
$328M
| $6.02K | ﹤0.01% |
146
-88
| -38% | -$3.44K |
|
|
MBX
2432
MBX Biosciences
MBX
$3.03B
| $6.02K | ﹤0.01% |
109
-840
| -89% | -$29.3K |
|
2433
Gevo
GEVO
$408M
| $6.01K | ﹤0.01% |
4,005
-3,748
| -48% | -$6.61K |
|
|
TE
2434
T1 Energy
TE
$1.49B
| $5.97K | ﹤0.01% |
630
-6,108
| -91% | -$43.4K |
|
2435
ANI Pharmaceuticals
ANIP
$1.61B
| $5.96K | ﹤0.01% |
72
-2,519
| -97% | -$202K |
|
|
PVLA
2436
Palvella Therapeutics
PVLA
$2.19B
| $5.96K | ﹤0.01% |
39
-27
| -41% | -$3.28K |
|
2437
Wendy's
WEN
$1.45B
| $5.95K | ﹤0.01% |
718
-2,816
| -80% | -$20.1K |
|
|
OLPX
2438
DELISTED
Olaplex Holdings
OLPX
| $5.95K | ﹤0.01% |
2,901
-1,749
| -38% | -$3.56K |
|
|
AKTS
2439
Aktis Oncology
AKTS
$1.39B
| $5.93K | ﹤0.01% |
184
-209
| -53% | -$4.29K |
|
2440
FRP Holdings
FRPH
$427M
| $5.92K | ﹤0.01% |
237
-149
| -39% | -$3.38K |
|
|
CLYM
2441
Climb Bio
CLYM
$913M
| $5.89K | ﹤0.01% |
+452
| New | +$4.67K |
|
2442
Chemung Financial Corp
CHMG
$407M
| $5.89K | ﹤0.01% |
79
-59
| -43% | -$3.95K |
|
|
RAPP
2443
Rapport Therapeutics
RAPP
$2.21B
| $5.88K | ﹤0.01% |
141
-834
| -86% | -$30.7K |
|
|
VOYG
2444
Voyager Technologies
VOYG
$2.16B
| $5.87K | ﹤0.01% |
182
-493
| -73% | -$17.1K |
|
2445
First Community Corp
FCCO
$319M
| $5.82K | ﹤0.01% |
178
-13
| -7% | -$399 |
|
2446
OraSure Technologies
OSUR
$234M
| $5.81K | ﹤0.01% |
1,302
-1,047
| -45% | -$3.7K |
|
2447
Amylyx Pharmaceuticals
AMLX
$3.78B
| $5.8K | ﹤0.01% |
323
-814
| -72% | -$12.6K |
|
2448
LSI Industries
LYTS
$729M
| $5.79K | ﹤0.01% |
218
-146
| -40% | -$3.37K |
|
2449
Compass Therapeutics
CMPX
$398M
| $5.79K | ﹤0.01% |
2,642
+198
| +8% | +$585 |
|
2450
Inhibrx
INBX
$1.68B
| $5.78K | ﹤0.01% |
61
-241
| -80% | -$24.1K |
|
Similar funds
SM
DGI
GAM
CDDEC
AAS
DCP
SDIC
MSRPS
Sterling Capital Management's Q2 2026 Portfolio in Review
As of Q2 2026, Sterling Capital Management held 3,465 positions worth $5.9B, up 12% from $5.28B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Sterling Capital Management's Q2 2026 filing shows 250 new, 687 increased, 2,249 reduced and 176 closed positions. Its largest new stake was Coca-Cola Europacific Partners: 217,119 shares worth $21.7M. The largest sale was Marvell Technology, an estimated $47.2M.
By sector, the portfolio is most concentrated in Miscellaneous at 21% of assets, up from 17% a quarter earlier, followed by Technology and Financials.
- Sterling Capital Management's largest Q2 2026 buy was Coca-Cola Europacific Partners: 217,119 shares worth $21.7M.
- Sterling Capital Management added most to Philip Morris in Q2 2026, an estimated $43.1M increase.
- Sterling Capital Management's biggest Q2 2026 reduction was Marvell Technology, cutting an estimated $47.2M.
- Sterling Capital Management fully exited Coterra Energy in Q2 2026, selling an estimated $34.4M.
- Sterling Capital Management's ten largest holdings make up 24% of its $5.9B portfolio in Q2 2026.
- Sterling Capital Management opened 250 new positions and closed 176 in Q2 2026.
- Sterling Capital Management's portfolio value rose 12% quarter-over-quarter to $5.9B.
Based on Sterling Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.